University of Leeds Expands Structural Biology With Purchase of Multiple Titan Krios TEMs From FEI
November 09 2015 - 7:01AM
FEI (NASDAQ:FEIC) today announced the receipt of a significant
order for two Titan Krios™ cryo transmission electron microscopes
(cryo-TEMs) from the University of Leeds, based in the United
Kingdom. The Titan Krios is the most powerful high-resolution
electron microscope for two-dimensional (2D) and three-dimensional
(3D) characterization of protein structures and protein complexes.
“The Titan Krios is an amazingly powerful tool for
structural biology that is in huge demand by researchers right
now,” said Dr. Neil Ranson, Associate Professor, School of
Molecular and Cellular Biology, University of Leeds. “Currently,
there are only two Titan Krios systems in the U.K., with a couple
more on the way. There is an insatiable demand for time on
microscopes with these capabilities, and access is very difficult
to come by. We are very excited to be able to purchase two Titan
Krios systems with direct electron detecting cameras; they will
help to establish Leeds as one of the leading centers for cryo-TEM
research in the U.K. and in the world.”
“Cryo-TEM is undergoing unprecedented growth
because improvements in microscopes and detectors now enable
close-to-atomic resolution structures for many biological systems,”
said Professor Sheena Radford, Astbury Professor of Biophysics and
Director of the Astbury Centre. “However the full potential of
cryo-EM will come as a result of the synergy with other
technologies, such as X-ray diffraction (XRD) and nuclear magnetic
resonance spectrometry (NMR). The University of Leeds is also
acquiring a new, state-of-the-art 950MHz NMR instrument dedicated
to biological research in the Astbury Centre.”
Peter Fruhstorfer, FEI’s Vice President and General
Manager of the Life Sciences business, stated, “We are delighted
that the University of Leeds has selected the Titan Krios TEM, and
we anticipate great results from the University’s combined use of
cryo-TEM, with XRD and NMR technology.” He adds, “The ability to
purchase two systems is significant and will give the University
the flexibility to conduct not only its own structural biology
research, but also to build collaborations with researchers at
other universities and institutions.”
The two Krios systems were purchased as part of a
£17M investment from the University’s strategic reserves, an
indication of the highest priority given to the acquisition by the
University’s leaders. The initiative is also supported by a £1M
award from the Wellcome Trust to support biomedical discovery.
The installation of the systems will begin in March
2016. For more information about the structural biology solutions
from FEI, visit
http://www.fei.com/life-sciences/structural-biology.
About the University of LeedsThe
University of Leeds is one of the largest higher education
institutions in the UK, with more than 31,000 students from 147
different countries, and a member of the Russell Group
research-intensive universities. We are a top 10 university for
research and impact power in the UK, according to the 2014 Research
Excellence Framework, and positioned as one of the top 100 best
universities in the world in the 2015 QS World University
Rankings. www.leeds.ac.uk
About FEIFEI Company (Nasdaq:FEIC)
designs, manufactures and supports a broad range of
high-performance microscopy workflow solutions that provide images
and answers at the micro-, nano- and picometer scales. Its
innovation and leadership enable customers in industry and science
to increase productivity and make breakthrough discoveries.
Headquartered in Hillsboro, Ore., USA, FEI has over 2,600 employees
and sales and service operations in more than 50 countries around
the world. More information can be found at: www.fei.com.
FEI Safe Harbor Statement This news release
contains forward-looking statements that include statements
regarding the performance capabilities and benefits of the Titan
Krios TEM. Factors that could affect these forward-looking
statements include but are not limited to our ability to
manufacture, ship, deliver and install the tools, solutions or
software as expected; failure of the product or technology to
perform as expected; unexpected technology problems and challenges;
changes to the technology; the inability of FEI, its suppliers or
project partners to make the technological advances required for
the technology to achieve anticipated results; the inability to
develop a workflow between the Titan Krios TEM and other
technologies such as XRD and NMR; and the inability of the customer
to deploy the tools or develop and deploy the expected new
applications. Please also refer to our Form 10-K, Forms 10-Q, Forms
8-K and other filings with the U.S. Securities and Exchange
Commission for additional information on these factors and other
factors that could cause actual results to differ materially from
the forward-looking statements. FEI assumes no duty to update
forward-looking statements.
For more information contact:
Sandy Fewkes (media contact)
MindWrite Communications, Inc.
+1 408 224 4024
sandy@mind-write.com
FEI Company
Jason Willey (investors and analysts)
Investor Relations Director
+1 503 726 2533
jason.willey@fei.com
Fei Company (MM) (NASDAQ:FEIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fei Company (MM) (NASDAQ:FEIC)
Historical Stock Chart
From Apr 2023 to Apr 2024